Acanthamoeba genotype T4 from the UK and Iran and isolation of the T2 genotype from clinical isolates by Maghsood, A.H. et al.
Journal of Medical Microbiology (2005), 54, 755–759 DOI 10.1099/jmm.0.45970-0




Received 30 November 2004
Accepted 15 March 2005
Acanthamoeba genotype T4 from the UK and Iran
and isolation of the T2 genotype from clinical isolates
Amir Hossein Maghsood,1,2 James Sissons,2 Mostafa Rezaian,1
Debbie Nolder,3 David Warhurst3 and Naveed Ahmed Khan2
1School of Biological and Chemical Sciences, Birkbeck College, University of London,
London WC1E 7HX, UK
2Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of
Medical Sciences, Tehran, 14155-6446, Iran
3Diagnostic Parasitology Laboratory, London School of Hygiene and Tropical Medicine, London, UK
The majority of the keratitis-causing Acanthamoeba isolates are genotype T4. In an attempt to
determine whether predominance of T4 isolates in Acanthamoeba keratitis is due to greater
virulence or greater prevalence of this genotype,Acanthamoeba genotypes were determined for 13
keratitis isolates and 12 environmental isolates from Iran. Among 13 clinical isolates, eight (61.5%)
belonged to T4, two (15.3%) belonged to T3 and three (23%) belonged to the T2 genotype. In
contrast, the majority of 12 environmental isolates tested in the present study belonged to T2 (7/12,
58.3%), followedby 4/12T4 isolates (33.3%). In addition, the genotypes of six newAcanthamoeba
isolates from UK keratitis cases were determined. Of these, five (83.3%) belonged to T4 and one
was T3 (16.6%), supporting the expected high frequency of T4 in Acanthamoeba keratitis. In total,
the genotypes of 24 Acanthamoeba keratitis isolates from the UK and Iran were determined. Of
these, 17 belonged to T4 (70.8%), three belonged to T2 (12.5%), three belonged to T3 (12.5%)
and one belonged to T11 (4.1%), confirming that T4 is the predominant genotype (2 ¼ 4.167;
P ¼ 0.0412) in Acanthamoeba keratitis.
INTRODUCTION
Acanthamoeba are ubiquitous organisms found in a variety
of environments including soil, water, air, food items,
humidifiers, dialysis units and healthy individuals (reviewed
by Khan, 2003; Marciano-Cabral & Cabral, 2003; Schuster &
Visvesvara, 2004). Based on their ecological distribution,
there is circulation ofAcanthamoeba strains between humans
and the environment. Acanthamoeba are opportunistic
causative agents of nasopharyngeal and cutaneous infections,
painful blinding keratitis and fatal Acanthamoeba granulo-
matous encephalitis (Khan, 2003; Marciano-Cabral & Cab-
ral, 2003; Schuster & Visvesvara, 2004). The difficulty in
assigning an explicit role of Acanthamoeba in infections is
because Acanthamoeba are heterogeneous and only certain
subgroups may be pathogenic. Recent advances in the
taxonomy of Acanthamoeba have led to the identification
of the pathogenic subgroups. The genus Acanthamoeba has
been classified into 15 different genotypes (T1–T15) based
on rRNA gene sequencing (Gast, 2001; Stothard et al., 1998;
Schuster & Visvesvara, 2004). To date, only isolates belong-
ing to the T3, T4, T6 and T11 genotypes have been associated
with Acanthamoeba keratitis (Booton et al., 2002; De
Jonckheere, 2003; Khan et al., 2002; Ledee et al., 1996;
Stothard et al., 1998; Walochnik et al., 2000), and a large
number of studies have identified T4 as the predominant
keratitis-causing genotype. Indeed more than 90% of
Acanthamoeba keratitis cases in literature reports have been
caused by T4 isolates. As suggested before, the frequent
involvement of T4 isolates in Acanthamoeba keratitis may be
due to their greater abundance in the environment and thus
they are most likely to be picked up by the susceptible hosts,
or because T4 isolates possess properties that enable them to
be more virulent, or both. In an attempt to clarify this, we
determined the environmental and clinical distribution of
Acanthamoeba in Iran. We tested 13 Acanthamoeba keratitis
cases presented during 1998–2003 at the Tehran University
of Medical Sciences, Iran. In addition, Acanthamoeba from
environmental sources from widespread geographic loca-
tions were isolated and identified at the genotype level using
rRNA gene sequencing.
METHODS
Clinical isolates. During 1998–2003, specimens from keratitis pa-
tients were tested for the presence of Acanthamoeba at the DepartmentAbbreviation: HCEC, human corneal epithelial cell.
of Parasitology and Mycology, School of Public Health, Tehran
University of Medical Sciences, Tehran, Iran. A total of 52 keratitis
cases was tested. To determine the presence of Acanthamoeba, speci-
mens (from contact lenses or corneal biopsies) were inoculated on to
non-nutrient agar (Oxoid) plates seeded with Enterobacter aerogenes
(formerly known asKlebsiella aerogenes). Plates were incubated at 30 8C
and observed daily for the presence of amoebae as previously described
(Khan & Paget, 2002).
Environmental isolates. Water samples from different cities in Iran
(Table 1) were collected and tested for the presence of Acanthamoeba.
For each sample, approximately 100–500 ml water was filtered through
a 0.45 m pore-size filter. Filters were inoculated on to non-nutrient
agar plates overlaid with E. aerogenes as described above. Acanthamoeba
were identified at the genus level, based on morphological character-
istics of trophozoites and cysts using phase-contrast microscopy.
Acanthamoeba were axenically cultivated in PYG medium (0.75%,
w/v, proteose peptone; 0.75%, w/v, yeast extract; and 1.5%, w/v,
glucose) at 30 8C as described previously (Khan & Paget, 2002).
Our previous studies have isolated Acanthamoeba from other geo-
graphic locations including theUK (Khan et al., 2002) and these isolates
were compared in the present study. In addition, Acanthamoeba spp.
were isolated from six new keratitis patients in the UK (Table 1),
identified at the genotype level using rRNA gene sequencing and used in
comparative studies.
PCR analysis. To confirm the identity of Acanthamoeba, PCR
reactions were performed using genus-specific primers as previously
described (Khan et al., 2001). Briefly, total DNAwas extracted using the
InstaGene matrix (Chelex; Bio-Rad) method as follows. Approximately
103 cells (counted using a haemocytometer) were incubated with 30 l
Chelex. Tubes were incubated at 56 8C for 20 min, followed by a 10 min
incubation at 99.9 8C and finally centrifuged at 10 000 g for 5 min. The
supernatants containing DNA were used as the template for PCR.
Primer sequences were 59-TTTGAATTCGCTCCAATAGCGTATATT
AA-39 and 59-TTTGAATTCAGAAAGAGCTATCAATCTGT-39 (Kong
& Chung, 1996). PCR was performed in a volume of 50 l containing
1.25 U Taq polymerase (Qiagen), 0.1–1.0 ng DNA, 200 M dNTPs,
Table 1. Acanthamoeba isolates tested in the present study
No. Patient no. Source Species Genotype
(a) Environmental isolates (water samples)
1 1-II Fountain pool water, Shariati square, Hamedan, Iran Acanthamoeba palestinensis T2
2 3-I Fountain pool water, Imam square, Hamedan, Iran A. palestinensis T2
3 6-V Pond water, Estakhr-e Abas-abad, Hamedan, Iran Acanthamoeba castellanii T4
4 7-S Pool water, Mellat Park, Hamedan, Iran A. palestinensis T2
5 8-II Fountain pool water, Tehran, Tehran University, Iran A. castellanii T4
6 8-III Fountain pool water, Tehran, Tehran University, Iran ND* ND*
7 9-S Fountain pool water, Laleh Park, Tehran, Iran A. palestinensis T2
8 16-I Fountain pool water, Ramsar, Shahed University, Iran A. palestinensis T2
9 19-I Fountain pool water, Babataher square, Hamedan, Iran A. palestinensis T2
10 21-II Fountain pool water, Tonkabon, Imam square, Iran A. castellanii T4
11 24-I Fountain pool water, Ramsar, Shahrivar square, Iran A. castellanii T4
12 27-II Waterfalls, Ganj-nameh, Hamedan, Iran A. palestinensis T2
(b) Clinical isolates (keratitis patients)
13 30 Contact lens (Acanthamoeba keratitis patient), Iran A. castellanii T4
14 52 Contact lens (Acanthamoeba keratitis patient), Iran A. castellanii T4
15 53 Contact lens (Acanthamoeba keratitis patient), Iran Acanthamoeba griffini T3
16 54 Corneal tissue (Acanthamoeba keratitis patient), Iran A. palestinensis T2
17 55 Contact lens (Acanthamoeba keratitis patient), Iran A. castellanii T4
18 56 Contact lens (Acanthamoeba keratitis patient), Iran A. griffini T3
19 58 Contact lens (Acanthamoeba keratitis patient), Iran A. castellanii T4
20 59 Contact lens (Acanthamoeba keratitis patient), Iran A. castellanii T4
21 60 Contact lens (Acanthamoeba keratitis patient), Iran A. castellanii T4
22 61 Contact lens (Acanthamoeba keratitis patient), Iran A. castellanii T4
23 62 Contact lens (Acanthamoeba keratitis patient), Iran A. castellanii T4
24 64 Contact lens (corneal trauma by insect), Iran A. palestinensis T2
25 65 Contact lens (Acanthamoeba keratitis patient), Iran A. palestinensis T2
26 515 UK keratitis A. griffini T3
27 771 UK keratitis A. castellanii T4
28 984 UK keratitis A. castellanii T4
29 1117 UK keratitis A. castellanii T4
30 1230 UK keratitis A. castellanii T4
31 1311 UK keratitis A. castellanii T4
*Acanthamoeba, but species/genotype not determined. This sample was omitted from the statistical analysis of association with genotype, i.e. only 11
environmental samples were included.
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4 mM MgCl2 and 0.5 M primer. PCR reactions were performed at
94 8C for 1 min, 55 8C for 1 min and 72 8C for 2 min for 30 cycles, with a
final elongation step of 10 min at 72 8C. Amplified DNA was electro-
phoresed on a 2% agarose gel, stained and visualized under UV
illumination.
18S rRNA gene sequencing. For 18S rRNA gene sequencing,
amplified DNA products were directly sequenced with an automated
fluorescent sequencing system using a LI-COR 4200DNA sequencer for
diagnostic fragment 3 using primer 892C (59-GTCAGAGGTGAA
ATTCTTGG-39) (Booton et al., 2002) and identified at the genotype
level by comparisonwith the availableAcanthamoebaDNAsequences in
GenBank or by comparison with the Acanthamoeba DNA sequence
database (Department of Molecular Genetics, The Ohio State Uni-
versity, OH,USA). Diagnostic fragment 3 sequences for the new isolates
are available upon request from N. A. Khan.
Cytotoxicity assay. For some Acanthamoeba isolates, cytotoxicity
assays were performed as previously described (Khan & Tareen, 2003).
Briefly, immortalized human corneal epithelial cells (HCECs) were
grown to confluency in 24-well plates in supplementary hormonal
epithelial medium (15%, w/v, fetal bovine serum; 40 g gentamicin
ml1; 5 g insulin ml1; 0.1 g cholera toxin ml1; vitamins; 40%
Hanks F12; 40% Dulbecco’s modified Eagle’s medium; 0.5% DMSO;
10 ng epidermal growth factor ml1) (Invitrogen) at 37 8C in a 5%CO2
incubator as previously described (Araki-Sasaki et al., 2000). Acantha-
moeba isolates (5 3 105 amoebae per well) were incubated with cell
monolayers in serum-free medium (RPMI 1640 containing 2 mM
glutamine, 1 mM pyruvate and non-essential amino acids) at 37 8C in
a 5%CO2 incubator for up to 24 h. At the end of this incubation period,
supernatants were collected and cytotoxicity was determined by meas-
uring lactate dehydrogenase release using a cytotoxicity detection kit
(Roche Applied Science) as previously described (Khan & Tareen,
2003).
RESULTS AND DISCUSSION
Isolation of Acanthamoeba from the clinical
specimens in Iran
Of 52 specimens taken from keratitis patients in Iran, 13were
found to contain Acanthamoeba, seven from women
(53.9%) and six from men (46.1%); their ages ranged from
15 to 54 years (mean 22 years). Twelve patients (92.3%)wore
soft contact lenses and one patient (7.7%) wore hard lenses.
Patients were treated with topical application of propami-
dine isethionate (Brolene) plus Neosporin (neomycin, poly-
myxin B sulfates and bacitracin). Twelve patients responded
to therapywith improved clinical symptoms and no report of
recurrence, indicating successful treatment. One patient
(#64) did not respond to anti-amoebic drugs and a corneal
graft was performed. This patient wore hard lenses and while
travelling on amotorcycle an insect had entered his right eye.
He rubbed his eye while wearing a contact lens, which
resulted in corneal trauma. The clinical signs of Acantha-
moeba keratitis followed soon after and included severe pain,
photophobia and stromal infiltrates. Within 20 days, he was
diagnosed with Acanthamoeba keratitis and anti-amoebic
therapy was initiated but showed no response. However, the




To determine the distribution of Acanthamoeba in the
environmental samples in Iran, 12 Acanthamoeba were
isolated from water samples obtained from different cities
(Table 1). Acanthamoeba were isolated based on morpholo-
gical characteristics of trophozoites and cysts. Overall, these
results suggested a wide environmental distribution of
Acanthamoeba from various geographic locations in Iran.
The identity of both clinical and environmental isolates was
further confirmed using PCR analysis as described in Meth-
ods (data not shown). Acanthamoeba were successfully
cultured in PYGmedium containing penicillin (100 Uml1)
and streptomycin (100 gml1) at 30 8C, except for one
environmental isolate (8-III).
Molecular typing of clinical isolates of
Acanthamoeba from Iran
In this study, 13Acanthamoeba keratitis caseswere identified.
Among these, eight (61.5%) isolates belonged to the T4
genotype, two (15.3%) belonged to T3 and three (23%)
belonged to the T2 genotype (Table 2). This is the first time
that Acanthamoeba isolates belonging to the T2 genotype
have been linked with Acanthamoeba keratitis. Of interest,
patient #64, who was non-responsive to anti-amoebic
therapy, was infected with a T2 isolate. To determine the
pathogenic potential of the three T2 isolates (#54, #64 and
#65), in vitro cytotoxicity assays were performed. We ob-
served that two Acanthamoeba isolates (#64 and #65)
produced more than 90% HCEC cytotoxicity and were
considered as potential pathogens. However, #54 exhibited
minimal HCEC cytotoxicity (, 10%) and was considered as
a weak or non-pathogen. Overall, these data indicated that
themajority of keratitis-causing isolates in Iran belong to the
T4 genotype.
T2 is a widely distributed genotype in the
environmental samples isolated from Iran
To determine the environmental distribution of Acantha-
moeba in Iran, amoebae were isolated from 12water samples.
Out of these, seven (58.3%) belonged to the T2 genotype and
four belonged to T4 (33.3%), while the Rns sequence of one
(8-III) (8.3%) was not determined (Table 2). These findings
indicated that T2 is a widely distributed genotype (followed
by T4) in the water samples tested from Iran.
Clinical and environmental distribution of
Acanthamoeba from other geographic locations
For comparison of clinical isolates, 11 Acanthamoeba kera-
titis isolates from the UK were used (Khan et al., 2002, plus
the six newAcanthamoeba keratitis cases tested in the present
study; Table 1). Of these, nine isolates (81.8%) belonged to
the T4 genotype, one belonged to T3 (9.1%) and one
belonged to T11 (9.1%) (Table 2). In total, 24Acanthamoeba
keratitis isolates from the UK and Iran were tested. Of these
17 belonged to T4 (70.8%), three belonged to T2 (12.5%),
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three belonged to T3 (12.5%) and one belonged to T11
(4.1%), confirming that T4 is the predominant genotype
(2 ¼ 4.167, P ¼ 0.0412) in Acanthamoeba keratitis.
For comparison of the environmental isolates, nineAcantha-
moeba isolates from the UK were tested as previously
described (Khan et al., 2002; Khan & Paget, 2002). Among
these, four isolates (44.4%) belonged to T4, two belonged to
T2 (22.2%), one belonged to T3 (11.1%) and two belonged
to T7 (22.2%) (Table 2). It is important to note that, except
for the T4 isolates, the majority of amoebae were isolated
from soil samples. Of interest, both T7 isolates were from soil
samples.
Acanthamoeba are causative agents of painful eye infections,
which can lead to blindness. They are one of the most
ubiquitous organisms and have been classified into 15
different genotypes. In an attempt to correlate pathogenicity
with certain genotypes, several studies have identified T4 as
the major keratitis-causing genotype. However, whether the
increased ability of T4 isolates to produce keratitis is due to
their greater virulence or their greater prevalence is some-
what unclear. In this study, we tested clinical and environ-
mental isolates of Acanthamoeba from a variety of sources
and various geographic locations in the UK and Iran. The
majority of clinical isolates tested in our study belonged to
the T4 genotype, consistent with previous studies. Among
the environmental isolates, T4 was again the predominant
genotype in the UK, but T2 was predominant in Iran within
the limited number of samples tested.
One of the interesting findings in our study was the isolation
of T2 isolates from three keratitis patients (#54, #64, #65). Of
these, #65 exhibited the characteristics of Acanthamoeba
keratitis. In addition, #65 received anti-acanthamoebic
chemotherapy with a successful outcome, indicating
Acanthamoeba as the causative agent. As quoted by De
Jonckheere (2003) and others, ‘contact lens cases are the
breeding grounds for Acanthamoeba’, and in the absence of a
mixed infection, it is reasonable to presume that the T2
isolate was the causative agent. This is the first time that
Acanthamoeba isolates belonging to the T2 genotype have
been linked with Acanthamoeba keratitis. This is in contrast
to previous studies, which showed that a T2 isolate (CCAP
1501/3c) exhibited minimal binding and minimal cytotoxi-
city to the host cells (Alsam et al., 2003; Khan et al., 2002) and
was considered as a weak or non-pathogen. There are several
possible explanations for these findings: the T2 genotypemay
consist of both pathogenic and weakly or non-pathogenic
isolates (since rRNA gene sequence information is not a
determinant for pathogenicity), or T2 isolates may have
diverse virulence properties and individual strains (current
or new isolates) should be tested for their virulence before
designating them pathogens or non-pathogens. Alterna-
tively, a more feasible scheme will be to subdivide the T2
genotype into two separate sequence types based on theirRns
sequences. In support of this, Stothard et al. (1998) have
shown that, within the T2 genotype, a sequence dissimilarity
of 4.9% exists between CCAP 1501/3c and ATCC 30871.
Comparison of CCAP 1501/3c with another T2 isolate
(ATCC 50252) also revealed similar differences (4.5%)
(Stothard et al., 1998). These differences are very close to
the current cut-off limit of 5% between different genotypes.
Thus we propose that T2 isolates should be subdivided into
two separate groups, T2A and T2B, with a sequence dissim-
ilarity of 4% or more. This may help to differentiate
pathogenic and non-pathogenic isolates within this geno-
type. Further studies involving Acanthamoeba belonging to
the T2 genotype with CCAP 1501/3c-like Rns sequences and
more detailed analysis of their properties will clarify the need
for two separate groups in this genotype.
Another intriguing finding was the inability of one Acantha-
moeba isolate (#54 from the contact lens of a keratitis patient)
to produce host-cell cytotoxicity, suggesting that it has weak
Table 2. Comparison of the clinical and environmental distribu-
tion of Acanthamoeba in the UK and Iran
Country No. of samples Genotype (%)
(a) Clinical isolates
UK 11 1 T3 (9.1)
9 T4 (81.8)
1 T11 (9.1)
Iran 13 3 T2 (23)
2 T3 (15.3)
8 T4 (61.5)




Association of T4 with clinical cases
T4* Not T4 Total
17 7 24
(b) Environmental isolates




Iran 12 7 T2 (58.3)
4 T4 (33.3)
1 ND





Association of T4 with environment
T4† Not T4 Total
8 12 20
*2 ¼ 4.167 with 1 degree of freedom. The two-tailed P value equals
0.0412, indicating significant association of T4 with clinical cases.
†2 ¼ 0.800 with 1 degree of freedom. The two-tailed P value equals
0.3711, indicating no significant association of T4 in the environmental
isolates.
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and/or non-pathogenic properties (, 10% cell death, as
compared with more than 70% cell death with other clinical
isolates). One explanation for this is that theremay have been
a mixed infection and T2 was isolated from the contact lens
even though it was not the causative agent. Future studies are
in progress to address these issues.
Despite the occasional cases ofAcanthamoeba keratitis due to
T2 (the present study), T3 (Ledee et al., 1996), T6 (Waloch-
nik et al., 2000) and T11 (Khan et al., 2002), the majority of
cases are due to the T4 genotype. This was further confirmed
in our study, as more than 80% of Acanthamoeba isolates
(UK keratitis) belonged to the T4 genotype. In addition, we
also determined that T4 was widely distributed in the
environmental samples isolated from the UK. These results,
together with previous findings, suggest that Acanthamoeba
isolates belonging to the T4 genotype naturally occur in the
environment and present potential reservoirs and therefore
sources of infection to susceptible hosts. As indicated above,
the repeated appearance of T4 isolates in keratitis may be due
to their greater pathogenicity (virulence properties), greater
transmissibility (i.e. they may be widely distributed in the
habitat where the probability of being picked up by humans
is very high), or a combination of both. To this end, we
determined T2 as the most abundant genotype, followed by
T4, in the environmental samples from Iran, even though the
number of T4 Iranian keratitis isolateswas higher than that of
T2 isolates (61.5 vs 23%). These findings demonstrated that
the abundance of T4 isolates in Acanthamoeba keratitis
patients is most likely due to their greater virulence and/or
properties that enhance their transmissibility, as well as their
ability to bind to contact lenses and their decreased suscept-
ibility to disinfectants. This raises additional questions about
the properties of T2 and T4 genotypes that enable them to be
the most widespread genotype in a given environment
among 15 different genotypes and whether these properties
play any role(s) in infection. Future studies that identify
virulence traits and genetic markers limited to certain
genotypes may help to clarify these issues.
Overall, there is a clear need for more detailed knowledge
about the distribution of each genotype in different environ-
ments and for detailed analyses of direct and indirect
virulence factors of environmental and clinical isolates of
each genotype. These findings will help us understand the
basis of differential distribution of genotypes in natural
habitats, and to some extent in clinical cases, and may
identify their differential properties contributing to disease,
which should allow the development of pre-emptive or
therapeutic measures against these serious infections.
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